Also trades as: ACT.DE (XETRA) · $vol 4M
ALZCF OTC
AlzChem Group AG
1W: +0.0%
1M: +0.0%
3M: -0.4%
YTD: +10.8%
1Y: +9.1%
3Y: +619.7%
$184.90
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$562M
+1.4% ▲
5Y CAGR: +8.2%
Gross Profit
$178M
-50.8% ▼
5Y CAGR: -6.7%
Operating Income
$83M
+5.9% ▲
5Y CAGR: +21.7%
Net Income
$63M
+17.3% ▲
5Y CAGR: +26.4%
EPS (Diluted)
$6.27
+18.1% ▲
5Y CAGR: +26.4%
EBITDA
$109M
+1.8% ▲
5Y CAGR: +15.1%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $422M | $542M | $541M | $554M | $562M |
| YoY Growth | +11.3% | +28.4% | -0.3% | +2.5% | +1.4% |
| Cost of Revenue | $154M | $259M | $242M | $194M | $384M |
| Gross Profit | $268M | $283M | $299M | $361M | $178M |
| Gross Margin | 63.5% | 52.1% | 55.3% | 65.1% | 31.6% |
| R&D Expenses | $10M | $11M | $11M | $11M | $11M |
| SG&A Expenses | $29M | $40M | $34M | $32M | $66M |
| Operating Expenses | $231M | $252M | $161M | $283M | $95M |
| Operating Income | $38M | $61M | $143M | $78M | $83M |
| Operating Margin | 9.0% | 11.3% | 26.5% | 14.1% | 14.7% |
| Interest Expense | $2M | $3M | $8M | $6M | $2M |
| Income Before Tax | $37M | $41M | $48M | $75M | $88M |
| Tax Expense | $9M | $11M | $13M | $21M | $24M |
| Net Income | $28M | $30M | $35M | $54M | $63M |
| Net Margin | 6.5% | 5.5% | 6.4% | 9.8% | 11.3% |
| EPS (Diluted) | $2.72 | $2.97 | $3.40 | $5.31 | $6.27 |
| EBITDA | $63M | $70M | $82M | $107M | $109M |
| Shares Outstanding | 10M | 10M | 10M | 10M | 10M |